ASX (ASXFY) News Today

ASX Limited (ASXFY) saw its ADR decline today as renewed US tariff threats weighed on key sectors and the ASX 200 pulled back from midweek highs, offsetting positive catalysts like new listings and strong US market gains.

• Positive Sentiment: Strong US tech rally driven by Nvidia’s $4 trillion milestone and bitcoin's surge boosted global market sentiment, lifting trading volumes on ASX. ASX 200 live: S&P, Nasdaq lift on Nvidia's $US4 trillion milestone; bitcoin hits $US116k
• Positive Sentiment: UniSuper’s proposal to allow dual-class shares could attract high-profile IPOs back to the ASX, enhancing future listing revenues. UniSuper says dual-class shares could lure founders back to the ASX
• Positive Sentiment: StepChange Holdings successfully debuted on the ASX, adding to listing fee revenues. StepChange Holdings makes ASX debut
• Positive Sentiment: Five FY25 retail shares topped growth charts, indicating strong sector momentum and bolstering trading activity. Ka-ching! 5 fastest growing ASX 200 retail shares of FY25
• Positive Sentiment: Four ASX 200 stocks outperformed the benchmark this week, driving overall market turnover. 4 ASX 200 stocks smashing the benchmark this week
• Neutral Sentiment: Beginner investors are advised to start with two ASX Vanguard ETFs, highlighting passive equity strategies. Beginner investors: Start with these 2 ASX Vanguard ETFs
• Neutral Sentiment: Weekly analysis compares quality vs value across four ASX stock pairs for buy, hold, or sell recommendations. Buy Hold Sell: Quality vs value across 4 ASX pairs
• Neutral Sentiment: Top weekly ASX runners include small caps Yandal, Imagion, Falcon, and Bayan, underpinning niche sector interest. ASX Runners of the Week: Yandal, Imagion, Falcon & Bayan
• Neutral Sentiment: A bank stock currently offers the highest dividend yield, signalling income-focused opportunities on the ASX. This is the ASX bank stock with the largest dividend yield right now
• Negative Sentiment: Donald Trump revived threats of pharmaceutical import tariffs, dragging down ASX health stocks and weighing on sector trading. Scott Power: ASX health falls as Trump revives pharma import tariff threat; CSL ‘undervalued’
• Negative Sentiment: The ASX 200 closed the week lower, pressured by geopolitical tariff concerns and a pullback from mid-week highs. ASX 200 closes the week lower on latest Trump development
• Negative Sentiment: Midday session saw gains evaporate as traders booked profits and global tariff fears resurfaced. Top 10 at 11: ASX pulls back from early gains; ASX biotechs go global

Overall, mixed catalysts left ASXFY trading lower, with tariff risks overshadowing listing growth and strong pockets of market performance.